Mirum pharmaceuticals to participate in upcoming investor conferences

Foster city, calif.--( business wire )--mirum pharmaceuticals, inc. (nasdaq: mirm), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences:
MIRM Ratings Summary
MIRM Quant Ranking